Snapshot

The TRIPS Compulsory Licensing during public health crisis pathway has been developed by the of World Trade Organization (WTO).

This pathway can be used where Patented pharmaceuticals for public health emergencies without prior authorization..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is Not applicable..